Volgen
Yash Agarwal
Yash Agarwal
Scientist, GentiBio (Prev. MIT, Boston University)
Geverifieerd e-mailadres voor alum.mit.edu - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Engineered immunogen binding to alum adjuvant enhances humoral immunity
TJ Moyer, Y Kato, W Abraham, JYH Chang, DW Kulp, N Watson, ...
Nature Medicine 26 (3), 430-440, 2020
1892020
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
Y Agarwal, LE Milling, JYH Chang, L Santollani, A Sheen, EA Lutz, ...
Nature biomedical engineering 6 (2), 129-143, 2022
632022
High-performance chemical-and light-inducible recombinases in mammalian cells and mice
BH Weinberg, JH Cho, Y Agarwal, NTH Pham, LD Caraballo, M Walkosz, ...
Nature communications 10 (1), 4845, 2019
502019
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains
KS Gordon, T Kyung, CR Perez, PV Holec, A Ramos, AQ Zhang, ...
Nature biomedical engineering 6 (7), 855-866, 2022
232022
Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade
C Wang, A Cui, M Bukenya, A Aung, D Pradhan, CA Whittaker, Y Agarwal, ...
Cell reports 37 (8), 2021
222021
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
EA Lutz, Y Agarwal, N Momin, SC Cowles, JR Palmeri, E Duong, V Hornet, ...
Proceedings of the National Academy of Sciences 119 (36), e2205983119, 2022
172022
Neoadjuvant STING activation, extended half-life IL2, and checkpoint blockade promote metastasis clearance via sustained NK-cell activation
LE Milling, D Garafola, Y Agarwal, S Wu, A Thomas, N Donahue, J Adams, ...
Cancer immunology research 10 (1), 26-39, 2022
102022
Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor models
A Sheen, Y Agarwal, KM Cheah, SC Cowles, JA Stinson, JR Palmeri, ...
Redox Biology 64, 102766, 2023
42023
Co‐anchoring of engineered immunogen and immunostimulatory cytokines to alum promotes enhanced‐humoral immunity
JYH Chang, Y Agarwal, KA Rodrigues, N Momin, K Ni, BJ Read, TJ Moyer, ...
Advanced Therapeutics 5 (7), 2100235, 2022
32022
Optimization of an alum-anchored clinical HIV vaccine candidate
KA Rodrigues, CA Cottrell, JM Steichen, B Groschel, W Abraham, H Suh, ...
npj Vaccines 8 (1), 117, 2023
12023
Reprogramming brain immunosurveillance with engineered cytokines
A Tabet, Y Agarwal, J Stinson, C Apra, V Will, M Manthey, N Momin, ...
bioRxiv, 2022.06. 21.497082, 2022
12022
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
DJ Irvine, KD Wittrup, T Moyer, Y Agarwal
US Patent 11,642,409, 2023
2023
738 Intratumoral administration of alum-tethered engineered inflammatory cytokines safely elicits potent local and systemic immunity
Y Agarwal, K Wittrup, D Irvine
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021
2021
BBF RFC 94: Type IIS Assembly for Bacterial Transcriptional Units: A Standardized Assembly Method for Building Bacterial Transcriptional Units Using the Type IIS Restriction …
TL Haddock, DM Densmore, E Appleton, S Carr, S Iverson, M De Freitas, ...
2015
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
Genetic Systems Engineering
P Vaidyanathan, E Appleton, C Madsen, CI Vasile, A Pacheco, I Haghighi, ...
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–16